Risk-Based Long-Term Screening for Hepatocellular Carcinoma Recurrence After Living Donor Liver Transplantation
โ Scribed by Hwang, S.; Moon, D.-B.; Ahn, C.-S.; Kim, K.-H.; Ha, T.-Y.; Song, G.-W.; Jung, D.-H.; Park, G.-C.; Lee, H.C.; Lee, Y.S.; Chung, Y.-H.; Abdulkarim, B.A.; Lee, S.-G.
- Book ID
- 122141280
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 991 KB
- Volume
- 45
- Category
- Article
- ISSN
- 0041-1345
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Several studies have reported higher rates of recurrent hepatocellular carcinoma (HCC) after living donor liver transplantation (LDLT) versus deceased donor liver transplantation (DDLT). It is unclear whether this difference is due to a specific biological effect unique to the LDLT procedure or to o
In regions with a limited deceased donor pool, living donor adult liver transplantation (LDALT) has become an important treatment modality for patients with hepatocellular carcinoma (HCC) and cirrhosis. Studies have shown higher recurrence rates of HCC after LDALT in comparison with deceased donor l